Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Clinical/translational cancer immunotherapy

Original research

Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity

Online download statistics by month:

Online download statistics by month: August 2020 to May 2022

	Abstract	Full	Pdf
Aug 2020	754	755	140
Sep 2020	832	831	88
Oct 2020	300	300	28
Nov 2020	168	167	28
Dec 2020	108	108	24
Jan 2021	143	143	25
Feb 2021	164	164	22
Mar 2021	112	112	30
Apr 2021	278	277	38
May 2021	255	255	35
Jun 2021	166	166	10
Jul 2021	69	69	16
Aug 2021	70	70	28
Sep 2021	113	114	22
Oct 2021	158	158	32
Nov 2021	136	137	38
Dec 2021	98	99	15
Jan 2022	98	110	27
Feb 2022	130	139	27
Mar 2022	142	150	46
Apr 2022	132	149	37
May 2022	149	157	35
Total	4575	4630	791